OGN vs SEM · P/E 3.4, rev $6.40B vs P/E 15, rev $1.31B
Organon & Co (OGN) versus Select Medical Holdings (SEM) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Select Medical Holdings (SEM) is a medical care facilities company listed on NYSE.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported SEM revenue for 2024-12-31 was $1.31B. Net income was $3.8M. Revenue was up 3.2% from 2024-09-30 to 2024-12-31. SEM currently screens at market cap $2.05B and trailing P/E 15.5.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. SEM currently screens at market cap $2.05B and trailing P/E 15.5.
Not investment advice. Open the OGN and SEM stock pages for the full models.
Not investment advice.